Verrica Pharmaceuticals Inc (NASDAQ:VRCA)

8.20
Delayed Data
As of Sep 25
 +0.37 / +4.73%
Today’s Change
6.02
Today|||52-Week Range
18.67
-48.40%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$210.4M

Company Description

Verrica Pharmaceuticals, Inc. operates as a clinical-stage medical dermatology company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its lead product VP-102, is a proprietary topical therapy used in common skin indications including Molluscum contagiosum and Verruca Vulgaris. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.

Contact Information

Verrica Pharmaceuticals, Inc.
10 North High Street
West Chester Pennsylvania 19380
P:(434) 453-3300
Investor Relations:

Employees

Shareholders

Mutual fund holders9.64%
Individual stakeholders59.50%
Other institutional23.23%

Top Executives

Ted WhitePresident, Chief Executive Officer & Director
A. Brian DavisChief Financial Officer
Gary GoldenbergChief Medical Officer
Eugene ScavolaExecutive Vice President-Technical Operations
Joe BonaccorsoChief Commercial Officer